OQS
TNGX icon

Occudo Quantitative Strategies’s Tango Therapeutics TNGX Stock Holding History

Occudo Quantitative Strategies’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-14,095
Closed -$159K – 1199
2023
Q3 		$159K Buy
+14,095
New +$85.9K 0.02% 830
2022
Q4 		– Sell
-21,520
Closed -$78K – 1368
2022
Q3 		$78K Buy
21,520
+10,445
+94% +$44.6K 0.01% 1054
2022
Q2 		$50K Buy
+11,075
New +$67.1K ﹤0.01% 1070

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Occudo Quantitative Strategies's TNGX Position: Q4 2023 in Review

Occudo Quantitative Strategies sold out of Tango Therapeutics (TNGX) in Q4 2023, closing a stake of 14,095 shares — an estimated $159K sold.

Occudo Quantitative Strategies first reported a position in TNGX in Q2 2022 and held it in 3 quarters. The position peaked at $159K in Q3 2023. 121 funds tracked by Wall St. Rank hold TNGX as of Q4 2023.

  • Occudo Quantitative Strategies reported no remaining Tango Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 14,095 Tango Therapeutics shares in Q4 2023, an estimated $159K.
  • Occudo Quantitative Strategies first reported a position in Tango Therapeutics in Q2 2022 and held it in 3 quarters.
  • Occudo Quantitative Strategies's Tango Therapeutics position peaked at $159K in Q3 2023.
  • 121 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2023.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2023, filed 14 Feb 2024.